Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT04971785 · COMPLETED
Trial details
- NCT number
- NCT04971785
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-09
- Primary completion
- 2024-11-12
- Enrollment
- 457
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.